China’s dominance in Rare Earth metals is hard to ignore, But for one lesser-known metal that fuels the U.S. defense sector, China’s grip is so tight that the U.S. now…
Cryptocurrency News
-
-
Cryptocurrency News
3 Reasons to Buy Nvidia Stock as the UBS Global Technology and AI Conference Gets Underway
by skolnesIt seems Nvidia (NASDAQ: NVDA) is a victim of its own success. After another incredible quarter in which it doubled its earnings per share (EPS) year over year, the chipmaker’s…
-
(Bloomberg) — South Korean President Yoon Suk Yeol’s surprise decision to impose martial law in South Korea for the first time in more than 40 years — and then just…
-
Cryptocurrency News
S&P 500, Nasdaq eke out records after jobs data surprises, Fed officials signal more cuts
by skolnesUS stocks closed mixed on Tuesday as investors digested fresh jobs data and new Fedspeak regarding the path forward for interest rates. The S&P 500 (^GSPC) and tech-heavy Nasdaq Composite…
-
Oil prices will fall to an average of $65 per barrel in 2025 amid an oversupply of crude and a backdrop of slowing demand as countries shift toward cleaner energies…
-
Electrical stock Enovix Corp (NASDAQ:ENVX) is down 1.6% at $10.04 today, on track for only its second loss in the last 11 sessions. Today’s pullback could be short-lived, too, as the…
-
Shares of data center cable company Credo Technology (NASDAQ: CRDO) rocketed on Tuesday, with shares up 47.3% as of 1:11 p.m. ET. The company reported earnings last night that not…
-
Cryptocurrency News
Pfizer’s New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments
by skolnesPfizer’s New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments Goldman Sachs hosted a meeting with Pfizer Inc’s (NYSE:PFE) newly appointed Chief Scientific Officer Chris Boshoff (effective…
-
(Bloomberg) — Intel Corp.’s search for a new chief executive officer will focus heavily on outsiders, with the chipmaker considering candidates such as Marvell Technology Inc. head Matt Murphy and…
-
Shares of leading organ transplant platform TransMedics (NASDAQ: TMDX) were down 14% as of noon ET on Wednesday, according to data provided by S&P Global Market Intelligence. TransMedics issued a…